Author: Herantis Pharma plc

Posted Date:

May 19, 2026

Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease

Herantis Pharma plc

May 19, 2026
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases

Herantis Pharma plc

March 16, 2026
Herantis Pharma releases 2H and FY 2025 report today

Herantis Pharma plc

March 5, 2026
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Herantis Pharma plc

February 19, 2026